Opinion|Videos|July 9, 2024
The Impact of Payer Coverage and Reimbursement on Biosimilars
Dr. Cannon leads a conversation navigating the impact of payer coverage on the uptake of biosimilars.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How are payer coverage and reimbursement policies impacting the uptake of biosimilars? What have you observed in your practice?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
2
TrumpRx Launch Brings Savings—and Uncertainty
3
Exploring Identity, Appearance Experiences Among Patients With Alopecia
4
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
5
